1:16-cv-12182 United States of America ex rel. v. Janssen Biotech, Inc.
Case Summary
The United States of America, as relator, is engaged in litigation against Janssen Biotech, Inc., with the latest docket entry showing opposition to a motion. This case likely involves a qui tam or whistleblower action under the False Claims Act or similar statutes, focusing on alleged misconduct by the defendant. The opposition indicates active contestation of procedural or substantive motions.
Stage
Motion practice
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • False Claims Act
- • Qui tam litigation
- • Motion opposition
- • Government enforcement
Case Timeline
1 event1:16-cv-12182 United States of America ex rel. v. Janssen Biotech, Inc.
In the case of United States of America ex rel. v. Janssen Biotech, Inc., the opposing party filed a response opposing a motion numbered 614. This means they disagreed with the request made in that motion and provided reasons to convince the court to deny it. Such oppositions are crucial as they influence the court's decisions on procedural or substantive issues in the case.